Destiny Pharma's Nasal Spray Project Already Delivering More Than Hoped For
(MENAFN- News Direct) London, UK | May 02, 2023 07:30 AM Eastern Daylight Time
--p
< />Destiny Pharma PLC (AIM:DEST, OTC:DTTYF) CEO Neil Clark speaks to Proactive after releasing fresh data from the update from a research collaboration into a novel biotherapeutic treatment for COVID-19 and influenza. Clark says that the project has already delivered "more than hoped for" and that it will be "really interesting to see where [it] goes next."
MENAFN02052023005728012573ID1106156273
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.